JPRN-UMIN000032665Recruiting未知
The efficacy and the utility of switching into glucagon like peptide-1 receptor agonist plus basal insulin therapy in type 2 diabetic patients treated with Basal-Bolus therapy. - The efficacy and the utility of switching from basal-bolus therapy to GLP-1 RA plus basal insulin therapy.
Department of Endocrinology, Nippon Medical School Chiba Hokusoh Hospital0 sites100 target enrollmentStarted: May 21, 2018Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Recruiting
- Sponsor
- Enrollment
- 100
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 20years-old to 75years-old (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Type 1 diabetes with severe liver disease, severe renal disease or severe heart disease with any carcinoma under pregnancy
Investigators
Similar Trials
Completed
Not Applicable
The evaluation of the efficacy of a switch from GnRH agonist to GnRH antagonist in prostate cancer patients who relapsed during combined androgen blockade.prostate cancerJPRN-UMIN000013514Tokai Urological Clinical Trial Group50
Active, not recruiting
Phase 1
Assessing the safety and efficacy of switching to Azarga (Brinzolamide/Timolol Fixed Combination), as replacement therapy in patients with uncontrolled intraocular pressure - not applicableEUCTR2009-015795-10-SIAlcon d.o.o.120
Recruiting
Not Applicable
The efficacy and safety of switching from linagliptin to once-weekly dulaglutide in hemodialysis patients with type 2 diabetes mellitus (pilot study)Type 2 diabetes mellitusJPRN-UMIN000021944Minamisenju Hospital20
Not yet recruiting
Phase 3
B/F/TAF to DTG/3TC Switch StudyHIV/AIDSPACTR202404870570433niversity of Nairobi240
Completed
Not Applicable
Investigation of efficacy and safety of switching from basal-bolus therapy to combination therapy with GLP-1 receptor agonist and basal insulin injection in type 2 diabetestype 2 diabetesJPRN-UMIN000013222Juntendo University Graduate School of Medicine30
